A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014)

NCT02180295 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: V212 Lot 1
BIOLOGICAL: V212 Lot 2
BIOLOGICAL: V212 Lot 3

Sponsor

Merck Sharp & Dohme LLC